<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Background and Aims </plain></SENT>
<SENT sid="1" pm="."><plain>The study was a repeated evaluation of the experience of capsule endoscopy (CE) in patients with cardiac pacemaker or implantable cardioverter defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Patients and Methods </plain></SENT>
<SENT sid="3" pm="."><plain>A standardized questionnaire was sent by the manufactors Given Imaging and Olympus to <z:hpo ids='HP_0000001'>all</z:hpo> centers in Germany, Austria, and Switzerland providing capsule endoscopy service </plain></SENT>
<SENT sid="4" pm="."><plain>The questionnaire covers the number of examined patients, monitoring during CE, check of the electric implants before and after CE, occurrence of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo>, quality of CE video, complications, indication of CE, and type of institution </plain></SENT>
<SENT sid="5" pm="."><plain>Results </plain></SENT>
<SENT sid="6" pm="."><plain>Overall 580 questionnaires were sent to the users </plain></SENT>
<SENT sid="7" pm="."><plain>26/5% (Germany/Austria + Switzerland) of the questionnaires were sent back anonymously to the authors </plain></SENT>
<SENT sid="8" pm="."><plain>114 centers (82 hospitals, 11 surgeries, 21 without specification) replied </plain></SENT>
<SENT sid="9" pm="."><plain>In 58 centers (51%), patients with cardiac pacemaker (n = 300) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e> (n = 80) underwent uneventful capsule endoscopy </plain></SENT>
<SENT sid="10" pm="."><plain>The predominant indication (patients with CP 97%, patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> 100%) was mid <z:hpo ids='HP_0002239'>gastrointestinal bleeding</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Conclusion </plain></SENT>
<SENT sid="12" pm="."><plain>The results of our inquiry show that in spite of formal contraindication CE is increasingly applied in <z:mp ids='MP_0001914'>bleeding</z:mp> patients with cardiac pacemakers/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e> and seems to be safe even in a large cohort </plain></SENT>
</text></document>